Are terminally ill patients dying in the ICU suitable for non-heart beating organ donation? by Revelly,  J. P. et al.
Intensive Care Med (2006) 32:708–712






Are terminally ill patients dying in the ICU
suitable for non-heart beating organ donation?
Received: 31 July 2005
Accepted: 14 February 2006
Published online: 14 March 2006
© Springer-Verlag 2006
Electronic supplementary material
The electronic reference of this article is
http://dx.doi.org/10.1007/s00134-006-0116-
7. The online full-text version of this article
includes electronic supplementary material.
This material is available to authorised users
and can be accessed by means of the ESM
button beneath the abstract or in the
structured full-text article. To cite or link to
this article you can use the above reference.
René Chioléro and Luca Imperatori are
members of the SwissFoundation to Support
Organ Donation.
J.-P. Revelly () · P. Maravic · R. Chioléro
Centre Hospitalier Universitaire Vaudois,










Centre Hospitalier Universitaire Vaudois,
Medical Intensive Care Unit,
1011 Lausanne, Switzerland
Abstract Objective: To evaluate
the feasibility of implementing a pro-
gram of controlled non-heart beating
organ donation, in patients under-
going the withdrawal of intensive
care treatment. Design and setting:
Prospective observational study. Med-
ical and Surgical ICUs in a tertiary
university hospital. Patients: Consec-
utive patients younger than 70 years
dying in the ICU after treatment
withdrawal for dire neurological prog-
nosis. Measurements and results: We
analyzed prospectively collected data
from the ICU clinical information
system. Seventy-three of 516 ICU
deaths (13%) were identified, equally
distributed among traumatic, stroke,
and anoxic brain injury. The manage-
ment and the course in these three
diagnostic categories were similar.
All patients underwent withdrawal of
mechanical ventilation and half were
extubated. Median time to death was
of 4.8 h (IQR 1.4–11.5). In 70% of
cases the patient received analgesia
and 30% sedation. Such treatment
was not related to earlier death. Hy-
potension was observed in 50% of
patients during the 30 min preceding
cardiac death. Conclusions: With
our current management of terminal
patients controlled non-heart beating
organ procedure may be difficult
due to the duration and variability of
the dying process. This observation
suggests that we can perform bet-
ter by evaluating this process more
closely.
Keywords Coma · Terminal care ·
Treatment withdrawal · Organ do-
nation · Non-heart beating organ
donor
Introduction
Insufficient procurement of organs from brain-dead
donors is the principle factor limiting access to solid organ
transplantation. There is evidence that some patients not
developing brain death criteria but ending in cardiac death
may be suitable for donation of kidney and in certain
situations liver or lung [1, 2], a process called non-heart
beating donation (NHBD). In the intensive care unit
(ICU) when the prognosis (in particular neurological) is
unambiguously dire, life-support treatments are futile and
should be withdrawn. In such situations controlled NHBD
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can be considered suitable [2]. This refers to the fact that in
such circumstances a treatment plan of palliative care can
be carefully explained to the next of kin. Once they have
understood and accepted this line of treatment, sufficient
time should be given for quiet communication with the
relatives so as to seek consent for NHBD before cardiac
death, or the relatives may spontaneously propose organ
donation. Continuous monitoring enables to pronounce
death following the cardiac arrest, in which case a surgical
team on standby can retrieve the organs immediately.
Patients presenting catastrophic neurological patholo-
gies are usually perceived as the most suitable for this ap-
proach by the healthcare team [3]. Although communica-
tion, ethical, and juridical barriers to this approach may
appear difficult, and in many countries, including our own,
certain of these obstacles have not yet been resolved, there
is emerging evidence that in favorable circumstances such
a procedure is feasible and can increase the number of
available organs for transplantation [4]. From published
literature [5, 6], it appears that the timing of the process
is vital to limit warm ischemia time. The lack of informa-
tion regarding the practical aspects of patient management
led us to investigate our own data on the process of with-
drawing treatment [7].
We studied a group of critically ill, preterminal patients
perceived as potential candidates for NHBDs to estimate
the feasibility of implementing an NHBD program at our
institution. We specifically evaluated the management and
the timing of death in patients undergoing the withdrawal




We analyzed all 516 patients suffering catastrophic brain
injury, defined as acute brain illness and unresponsive to
maximal medical and surgical treatment. Intensive care
treatment was withdrawn according to the recommen-
dations of the Swiss Academy of Medical Sciences [8],
a national committee issuing bioethical recommendations.
Due to patient incompetence the next of kin are informed
of the situation, of the focus on palliative care, and of the
plan to withdraw life-sustaining therapy. Oral consent by
the family is documented in the patient’s notes. Firstly,
vasoactive agents (if any) are withdrawn, followed by
withdrawal of mechanical ventilation, with discretionary
extubation. Sedative-analgesic drugs are administered to
relieve perceived respiratory distress, vegetative reactions,
and disturbing movements if deemed appropriate by the
attending physician and nurses. Family members are
encouraged to accompany their beloved one during this
period and to seek the assistance of a chaplain if required.
This procedure reflects current professional conduct and
complies with the local ethical and legal standards. There
are no existing institutional recommendations for this
process at present, apart from the recommendations of the
Swiss Academy of Medical Sciences [8].
Study design
In this observational study we considered patients under
the age of 70 years who were dying in the ICU between
1 January 2002 and 31 December 2004. The prospective
data were entered and analyzed in the computerized clin-
ical information system (CIS) of our medical and surgi-
cal ICUs. The CIS provides on-line information on patient
management and medical history. Physiological variables
from the monitors, ventilators, and laboratory results are
automatically entered every minute and validated by the
nurses and physicians. During end-of-life in the ICUs the
vital signs are usually not displayed on the monitors sur-
rounding the patient but are continuously recorded in the
database of the CIS. Administered drugs, procedures and
care are selected manually from a predefined scroll down
list. The CIS constitutes the nurses’ observation chart, and
this part of patient’s file is paperless.
Our institution’s ethics committee waived the require-
ment of informed consent for analysis of these data and
the anonymous publication of results. A nurse certified in
intensive care extracted the data while an attending ICU
physician validated and analyzed it. For each patient we
recorded: the diagnosis, Glasgow Coma Scale (GCS) score
at the time of treatment withdrawal, pharmacological treat-
ment, management of mechanical ventilation, and survival
time following treatment withdrawal. The total doses of se-
dation/analgesia administered (intravenous bolus and con-
tinuous perfusion) were divided by the duration of the ter-
minal phase and expressed as micrograms per kilogram
per hour. Hemodynamic values (mean arterial pressure and
heart rate) and SpO2 were recorded.
Descriptive statistics were calculated using JMP Sta-
tistical software version 5.1.2 (SAS Institute, Cary, N.C.,
USA). Data are presented as a mean ± SD or as median
(interquartile range, IQR). Comparisons between diagnos-
tic groups and between patients receiving or not receiving
analgesia or sedation, extubated or not were carried out by
the Wilcoxon test. Differences at the level of p < 0.05 were
considered statistically significant.
Results
Of the 516 patients dying in the ICU 73 fulfilled the above
criteria (Fig. 1); their characteristics are presented in
Table 1. There were 21 (29%) with traumatic brain injury,
25 (37%) anoxia, and 25 (34%) stroke (either ischemic,
subarachnoidial hemorrhage or cerebral hematoma). In
addition to the fact that head trauma patients were signif-
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Fig. 1 Patient selection from the general population of ICU patients
(2002–2004). Seventy three (13% of all ICU deaths) were identified
as potential non-heart beating donors
icantly younger, there were no differences between the
diagnostic groups. At the time of treatment withdrawal,
a GCS of 3 was recorded in 7 patients, 4 in 55, and 5 in
11, confirming the severity of the neurological disorder.
All patients were mechanically ventilated. Four
patients were treated with norepinephrine, which was in-
terrupted as the first measure. Mechanical ventilation was
withdrawn in all the other patients, followed by extubation
of 53%. Overall survival was 4.8 h (IQR 1.4–11.5). In
22% of cases the patient died during the first hour and in
31% after 2 h. Extubated patients survived significantly
Table 1 patients characteristics
Traumatic brain injury Stroke Anoxic brain injury All patients
(n = 21, 29%) (n = 25, 34%) (n = 27, 37%) (n = 73)
Age (years) 42 ± 14 53 ± 11 55 ± 12 50 ± 13
Survival time (h) 6.1 (2.4 – 12.5) 3.9 (1.3 – 11.5) 3.6 (1.0 – 9.8) 4.8 (1.4 – 11.5)
Died within 1 h 4 (19%) 5 (19%) 7 (26%) 16 (22%)
Died within 2 h 5 (24%) 8 (31%) 10 (37%) 23 (31%)
Extubation 11 (52%) 15 (60%) 13 (48%) 39 (53%)
Sedation 9 (42%) 4 (16%) 6 (22%) 19 (26%)
Dose of midazolam (µg−1 kg−1 h−1) 81 (42 – 125) 134 (70 – 161) 77 (47 – 343) 81 (54 – 145)
Analgesia 16 (76%) 18 (72%) 17 (63%) 51 (70%)
Dose of morphine (µg−1 kg−1 h−1) 77 (33 – 195) 72 (28 – 113) 77 (34 – 138) 75 (32 – 134)
longer, 9.4 h (3.3–15.3) vs. 3.1 h (1.2–6.6; p < 0.01; see
Electronic Supplementary Material, S.F1). These patients
died 7.6 h (1.5–13.6) after extubation (S.F2).
Analgesia was administered to 70% of the patients,
mainly as a morphine drip at an hourly dose of 75 µg/kg
(32–134). Sedation was administered to 26%, principally
midazolam at 81 µg/kg per hour (54–145). Analgesia
was administered to patients with a more protracted
course, and these patients therefore survived significantly
longer [6.6 h (2.8–13.2) vs. 1.9 h ([0.6–5.0), p < 0.04], but
survival time did not differ between patients receiving or
not receiving sedation [6.1 h (3.3–9.9) vs. 3.8 h (1.2–11.8),
p = 0.6].
Hemodynamic instability was frequent in all three
groups. Hypotension, defined as having a mean arterial
pressure lower than 60 mmHg, was observed in 80%
of patients 10 min before death. One-half of patients
(52%) were already hypotensive 30 min before death, and
one-third (37%) during their last hour of life (S.T1, S.F3).
Likewise, hypoxia defined as SpO2 below 90% was present
in 67% of patients 10 min before death, 71% at time minus
30 min, and 75% 1 h before (S.T1, S.F4). We could not
identify factors statistically correlated with the occurrence
of hypotension, hypoxia, or the duration of agony.
Discussion
Withdrawal of life-support treatment in patients present-
ing an unequivocally poor prognosis is considered a duty
for intensive care practitioners in most countries. This not
only allows the patient to die with dignity but also pro-
motes efficient ICU bed use [9]. This approach is well es-
tablished and has been socially accepted in our country for
many years [8]. Harvesting organs from NHBD is a far
more complex problem. This approach is based on a util-
itarian attitude, believing that organ procurement, a good
and useful action, enables some aspects of the death pro-
cess to be manipulated. Ethical issues have been discussed
in detail [1, 10], some aspects of which are still controver-
sial. Policies and regulations vary from country to country
and institution to institution depending on the emphasis put
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on respecting the integrity of a dying patient or on maxi-
mizing organ procurement.
The time course of withdrawing life-sustaining treat-
ment and cardiac arrest is entirely in accord with the result
of a large European study on unselected ICU patients [9]
and those of a study in the United States on patients suf-
fering neurological disaster [11]. We therefore believe that
a median survival time of several hours should be expected
in such circumstances, and we were not able to identify pa-
tient characteristics that would predict the precise time of
death, in particular with the use of sedation and analgesia,
or tracheal extubation. During agony, hypotension and hy-
poxia were frequently observed, although the tolerability
for transplanted organ viability is not settled yet.
Such an extent and variability in the time while await-
ing death can raise problems. It is difficult to establish
a NHBD program with a complete surgical team waiting
on standby, in some situations up to 1 day, for the cardiac
death of a potential organ donor. Hemodynamic instabil-
ity and hypoxia were frequently observed during agony,
although their effect on organ function could not be eval-
uated. To overcome this problem and have a better con-
trol of the process one could decide for example, limiting
the time between treatment withdrawal and cardiac death
to 1 h. Such a decision, from our analysis would result in
a decrease in this donor pool by 80%. It is equally worth
weighing the arguments for and against the setting up of
such a program for which there is only a 20% chance of
it actually happening. In addition to ethical, legal, and lo-
gistical aspects, family care and communication related to
organ donation request should be considered, as well as
the negative consequences of a failed NHBD. Recent evi-
dence shows that the death of a family member is a major
determinant of posttraumatic stress disorder for the next of
kin, and that sharing end-of-life decisions further increases
the risk of anxiety and depression [12]. The impact of con-
trolled NHBD on relatives of the deceased patient should
hence be carefully evaluated.
Actively accelerating the dying process could con-
ceivably resolve many issues. This would simplify the
organization and minimize hemodynamic instability be-
fore death. High doses of opiates and sedation would most
likely accomplish this goal. Outside the context of NHBD
this practice was in fact documented in a European obser-
vational study, with a significant shortening of the dying
process in 6.5% of ICU end-of-life situations [9]. The use
of high doses of sedation for the purpose of “improving”
NHBD goes far beyond the classical “double-effect” in the
use of medication to alleviate suffering. Such practice has
been proposed in an opinion paper highlighting the limited
harm to the dying patient compared to the benefit for the
receiver [3]. It has even been suggested, along these lines,
that the perfect process for controlled NHBD would be to
harvest organs without even bothering to wait for cardiac
arrest, since the patient is dying anyway and that he had
given his consent.
There are obviously numerous objections to this ap-
proach, based on the principle of beneficence. The use of
terminal sedation to deliberately accelerate death is ex-
plicitly condemned by the ethical recommendations in our
country [8]. Indeed, in our setting analgesia or sedation
was administered only when the family or the healthcare
workers felt uneasy, in particular when the patient pre-
sented signs of dysautonomy that suggest suffering or ab-
normal movements that were distressing. If terminal seda-
tion is necessary to facilitate controlled NHBD, this issue
should be openly addressed and debated by ethics com-
mittees. It is necessary to reach ethical, legal, and social
consensus before this approach can be implemented.
With our current management of terminal patients con-
trolled NHBD organ procedure may be difficult due to the
duration and variability of the dying process. This observa-
tion suggests that we can perform better by evaluating this
process more close. On the other hand, actions aiming to
accelerate dying, such as the administration of high doses
of sedation or analgesia, raise vast ethical questions.
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